3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
20
Plasma cell
2
Gastrointestinal
2
Thoracic
1
NET
1
Head & Neck
1
Genitourinary
1
Endocrine
1
CNS
1
Conditions
Neuroendocrine Tumors
69
Pheochromocytoma
8
Gastro-enteropancreatic neuroendocrine tumor
8
Carcinoma, Neuroendocrine
8
Paraganglioma
7
Carcinoid Tumor
7
Adenoma, Islet Cell
7
Sarcoma
6
Thyroid Neoplasms
5
Pancreatic Neoplasms
5
Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Mesothelioma
4
Carcinoma, Merkel Cell
4
Carcinoma
4
Stomach Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Meningioma
3
Liver Neoplasms
3
Gallbladder Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
NET
×
90 days
×
Clear all
NCT06881992
2026-05-18
Tumor HI
Rezolute
Phase 3
Recruiting
16 enrolled